{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06485089",
            "orgStudyIdInfo": {
                "id": "STUDY00160627"
            },
            "organization": {
                "fullName": "University of Kansas Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers",
            "officialTitle": "Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women With Obesity and Other Risk Factors for Breast Cancer",
            "therapeuticArea": [
                "Endocrinology",
                "Oncology and Hematology"
            ],
            "study": "effects-of-tirzepatide-on-blood-imaging-and-breast-tissue-biomarkers"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-20",
            "studyFirstSubmitQcDate": "2024-06-26",
            "studyFirstPostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Carol Fabian, MD",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "University of Kansas Medical Center"
            },
            "leadSponsor": {
                "name": "University of Kansas Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Evaluation of biomarkers for risk of developing breast cancer in women with obesity who are using tirzepatide to achieve weight loss.",
            "detailedDescription": "Women who are scheduled to take tirzepatide for weight loss will be assessed before and after taking drug for change in risk biomarkers. These include mammography, DXA scan, blood draw, and random periareolar fine needle aspiration (RPFNA) for acquisition of benign breast tissue."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity",
                "Breast Cancer Risk"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Blood, stool, benign breast tissue"
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "women using tirzepatide for weight loss",
                    "description": "Women attending the University of Kansas Medical Center (KUMC) Weight Management Clinic"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Feasibility of design as assessed by accrual rate of 1 or more per month over 12 months",
                    "description": "Accrual defined as signed consent and ompleting baseline proceedures",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Completion rate of 70% or more",
                    "description": "Completion of procedures for biomarker assessment after 3-6 months of tirzeptide",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in mammographic fibroglandular volume",
                    "description": "as measured by Volpara software baseline and 6 months",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Change in benign breast tissue proliferation",
                    "description": "Difference in baseline and off study Ki-67 in women with baseline Ki-67 of 1 % or higher",
                    "timeFrame": "3-6 months"
                },
                {
                    "measure": "Change in benign breast tissue estrogen response and ELF5 gene expression",
                    "description": "Difference in baseline and off study mRNA",
                    "timeFrame": "3-6 months"
                },
                {
                    "measure": "Assessment of GIP-R expression in breast tissue",
                    "description": "GIP- R mRNA and protein",
                    "timeFrame": "3-6 months"
                },
                {
                    "measure": "Change in selected adipokines, cytokines, hormones, IGF-1, alpha klotho",
                    "description": "change in blood levels with assays primarily by ELISA",
                    "timeFrame": "3-6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* \u2022 BMI 30-45 kg/m2\n\n  * Female\n  * Insurance approved or likely approved for tirzepatide clinical use \\*\n  * Additional risk factors for breast cancer other than obesity (any one or more) First or second degree with breast cancer Known high density on mammogram (heterogenous or extremely dense) Prior biopsy showing atypical hyperplasia or LCIS Prior treated DCIS Known carrier breast cancer predisposition gene mutation or known mutation in family member .\n\n    2- fold or higher estimated 10 year or lifetime risk compared to population by standard risk model (BCRAT, BCSC, IBIS\n\nExclusion Criteria:\n\n* \u2022 Subglandular breast implants (women with subpectoral implants are eligible if C cup or greater; breast can easily be pulled off the chest wall; and with approval of PI)\n\n  * Clinical contra-indication to incretin mimetics\n  * Insurance/third party has denied coverage and participant does not wish to do self-pay.\n  * Child-bearing potential and not on contraceptives\n  * Prior invasive breast cancer\n  * Currently taking any of the following medications: insulin, tamoxifen, raloxifene, letrozole, arimidex, exemestane, incretin mimetics.",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "Must be biologically female",
            "minimumAge": "40 Years",
            "maximumAge": "64 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "Women attending the KUMC Weight Management Clinic and approved or likely to be approved to start a clinical standard of care regimen of tirzepatide for weight loss.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Bruce F Kimler, PhD",
                    "role": "CONTACT",
                    "phone": "913-574-2796",
                    "email": "bkimler@kumc.edu"
                },
                {
                    "name": "Carol L Fabian, MD",
                    "role": "CONTACT",
                    "phone": "913-588-7791",
                    "email": "cfabian@kumc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Carol J Fabian, MD",
                    "affiliation": "University of Kansas Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Kansas Medical Center",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cathleen Beaver, MD",
                            "role": "CONTACT",
                            "phone": "913-588-3974",
                            "email": "cbeaver@kumc.edu"
                        },
                        {
                            "name": "Amy L Kreutzjans",
                            "role": "CONTACT",
                            "phone": "913-588-4521",
                            "email": "akreutzjans@kumc.edu"
                        },
                        {
                            "name": "Carol J Fabian, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Cathleen Beaver, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "University of Kansas Medical Center Breast Cancer Prevention Center",
                    "city": "Westwood",
                    "state": "Kansas",
                    "zip": "66208",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carol J Fabian, MD",
                            "role": "CONTACT",
                            "phone": "913-588-7791",
                            "email": "cfabian@kumc.edu"
                        },
                        {
                            "name": "Amy Kreutzjans",
                            "role": "CONTACT",
                            "phone": "913-588-4521",
                            "email": "akreutzjans@kumc.edu"
                        },
                        {
                            "name": "Cathleen Beaver, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.04056,
                        "lon": -94.6169
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Limited number of participants increases risk of identification of individuals"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000009765",
                    "term": "Obesity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M204206",
                    "name": "Tirzepatide",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}